Clara D Boyd1, Michael Tierney2, Eric M Wassermann2, Salvatore Spina2, Adrian L Oblak2, Bernardino Ghetti2, Jordan Grafman2, Edward Huey2. 1. From the Department of Neurology (C.D.B., E.H.), Columbia University Medical Center, New York, NY; Behavioral Neurology Unit (M.T., E.M.W.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; Department of Pathology and Laboratory Medicine (S.S., A.L.O., B.G.), Indiana University School of Medicine, Indianapolis; and Department of Physical Medicine and Rehabilitation (J.G.), Northwestern University Feinberg School of Medicine, Chicago IL. cdboyd@fastmail.us. 2. From the Department of Neurology (C.D.B., E.H.), Columbia University Medical Center, New York, NY; Behavioral Neurology Unit (M.T., E.M.W.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; Department of Pathology and Laboratory Medicine (S.S., A.L.O., B.G.), Indiana University School of Medicine, Indianapolis; and Department of Physical Medicine and Rehabilitation (J.G.), Northwestern University Feinberg School of Medicine, Chicago IL.
Abstract
OBJECTIVE: To use the Visual Object and Space Perception Battery (VOSP) to distinguish Alzheimer disease (AD) from non-AD pathology in corticobasal syndrome (CBS). METHODS: This clinicopathologic study assessed 36 patients with CBS on the VOSP. All were autopsied. The primary dependent variable was a binary pathologic outcome: patients with CBS who had primary pathologic diagnosis of AD (CBS-AD, n = 10) vs patients with CBS without primary pathologic diagnosis of AD (CBS-nonAD, n = 26). We also determined sensitivity and specificity of individual VOSP subtests. RESULTS: Patients with CBS-AD had younger onset (54.5 vs 63.6 years, p = 0.001) and lower memory scores on the Mattis Dementia Rating Scale-2 (16 vs 22 points, p = 0.003). Failure on the VOSP subtests Incomplete Letters (odds ratio [OR] 11.5, p = 0.006), Position Discrimination (OR 10.86, p = 0.008), Number Location (OR 12.27, p = 0.026), and Cube Analysis (OR 45.71 p = 0.0001) had significantly greater odds of CBS-AD than CBS-nonAD. These associations remained when adjusting for total Mattis Dementia Rating score, disease laterality, education, age, and sex. Receiver operating characteristic curves demonstrated significant accuracy for Incomplete Letters and all VOSP spatial subtests, with Cube Analysis performing best (area under the curve 0.91, p = 0.0004). CONCLUSIONS: In patients with CBS, failure on specific VOSP subtests is associated with greater odds of having underlying AD. There may be preferential involvement of the dorsal stream in CBS-AD. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that some subtests of the VOSP accurately distinguish patients with CBS-AD from those without AD pathology (e.g., Cube Analysis sensitivity 100%, specificity 77%).
OBJECTIVE: To use the Visual Object and Space Perception Battery (VOSP) to distinguish Alzheimer disease (AD) from non-AD pathology in corticobasal syndrome (CBS). METHODS: This clinicopathologic study assessed 36 patients with CBS on the VOSP. All were autopsied. The primary dependent variable was a binary pathologic outcome: patients with CBS who had primary pathologic diagnosis of AD (CBS-AD, n = 10) vs patients with CBS without primary pathologic diagnosis of AD (CBS-nonAD, n = 26). We also determined sensitivity and specificity of individual VOSP subtests. RESULTS:Patients with CBS-AD had younger onset (54.5 vs 63.6 years, p = 0.001) and lower memory scores on the Mattis Dementia Rating Scale-2 (16 vs 22 points, p = 0.003). Failure on the VOSP subtests Incomplete Letters (odds ratio [OR] 11.5, p = 0.006), Position Discrimination (OR 10.86, p = 0.008), Number Location (OR 12.27, p = 0.026), and Cube Analysis (OR 45.71 p = 0.0001) had significantly greater odds of CBS-AD than CBS-nonAD. These associations remained when adjusting for total Mattis Dementia Rating score, disease laterality, education, age, and sex. Receiver operating characteristic curves demonstrated significant accuracy for Incomplete Letters and all VOSP spatial subtests, with Cube Analysis performing best (area under the curve 0.91, p = 0.0004). CONCLUSIONS: In patients with CBS, failure on specific VOSP subtests is associated with greater odds of having underlying AD. There may be preferential involvement of the dorsal stream in CBS-AD. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that some subtests of the VOSP accurately distinguish patients with CBS-AD from those without AD pathology (e.g., Cube Analysis sensitivity 100%, specificity 77%).
Authors: J L Whitwell; C R Jack; B F Boeve; J E Parisi; J E Ahlskog; D A Drubach; M L Senjem; D S Knopman; R C Petersen; D W Dickson; K A Josephs Journal: Neurology Date: 2010-11-23 Impact factor: 9.910
Authors: William T Hu; Gregory W Rippon; Bradley F Boeve; David S Knopman; Ronald C Petersen; Joseph E Parisi; Keith A Josephs Journal: Mov Disord Date: 2009-07-15 Impact factor: 10.338
Authors: H Sakata; M Taira; M Kusunoki; A Murata; Y Tanaka; K Tsutsui Journal: Philos Trans R Soc Lond B Biol Sci Date: 1998-08-29 Impact factor: 6.237
Authors: I Litvan; Y Agid; C Goetz; J Jankovic; G K Wenning; J P Brandel; E C Lai; M Verny; K Ray-Chaudhuri; A McKee; K Jellinger; R K Pearce; J J Bartko Journal: Neurology Date: 1997-01 Impact factor: 9.910
Authors: I Litvan; J J Hauw; J J Bartko; P L Lantos; S E Daniel; D S Horoupian; A McKee; D Dickson; C Bancher; M Tabaton; K Jellinger; D W Anderson Journal: J Neuropathol Exp Neurol Date: 1996-01 Impact factor: 3.685
Authors: Colin Groot; B T Thomas Yeo; Jacob W Vogel; Xiuming Zhang; Nanbo Sun; Elizabeth C Mormino; Yolande A L Pijnenburg; Bruce L Miller; Howard J Rosen; Renaud La Joie; Frederik Barkhof; Philip Scheltens; Wiesje M van der Flier; Gil D Rabinovici; Rik Ossenkoppele Journal: Neurology Date: 2020-07-16 Impact factor: 9.910
Authors: Matteo Pardini; Edward D Huey; Salvatore Spina; William C Kreisl; Silvia Morbelli; Eric M Wassermann; Flavio Nobili; Bernardino Ghetti; Jordan Grafman Journal: Neurology Date: 2019-01-30 Impact factor: 9.910
Authors: Nobutaka Sakae; Keith A Josephs; Irene Litvan; Melissa E Murray; Ranjan Duara; Ryan J Uitti; Zbigniew K Wszolek; Jay van Gerpen; Neil R Graff-Radford; Dennis W Dickson Journal: Alzheimers Dement Date: 2019-08-06 Impact factor: 16.655
Authors: Sebastian J Crutch; Jonathan M Schott; Gil D Rabinovici; Melissa Murray; Julie S Snowden; Wiesje M van der Flier; Bradford C Dickerson; Rik Vandenberghe; Samrah Ahmed; Thomas H Bak; Bradley F Boeve; Christopher Butler; Stefano F Cappa; Mathieu Ceccaldi; Leonardo Cruz de Souza; Bruno Dubois; Olivier Felician; Douglas Galasko; Jonathan Graff-Radford; Neill R Graff-Radford; Patrick R Hof; Pierre Krolak-Salmon; Manja Lehmann; Eloi Magnin; Mario F Mendez; Peter J Nestor; Chiadi U Onyike; Victoria S Pelak; Yolande Pijnenburg; Silvia Primativo; Martin N Rossor; Natalie S Ryan; Philip Scheltens; Timothy J Shakespeare; Aida Suárez González; David F Tang-Wai; Keir X X Yong; Maria Carrillo; Nick C Fox Journal: Alzheimers Dement Date: 2017-03-02 Impact factor: 21.566